BYLINE: Denise Heady Newswise — A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center sheds new light on why tumors that have spread to the…
Read more Study could help explain why certain brain tumors don’t respond well to immunotherapyNewswise — New research in colorectal cancers directed by investigators at the Johns Hopkins Kimmel Cancer Center suggests that expression of transcription factors — proteins that help turn…
Read more Transcription Factors Contribute to Subtypes of Colorectal CancersNewswise — New Brunswick, N.J. July 1, 2023 – From the top of your head to your toes, sarcoma can grow in bones, muscles, tendons, cartilage, and any connective…
Read more 10 Quick Facts about Sarcoma, one of the Rarest CancersNewswise — HOUSTON ― A blood-based test developed by researchers at The University of Texas MD Anderson Cancer Center can predict an individual’s risk of dying from lung cancer when combined…
Read more Blood test aids in predicting lung cancer mortality riskRESEARCH SUMMARY Study Title: Early Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer Publication: Journal of Clinical Oncology Dana-Farber Cancer Institute authors: Jeremiah Wala; MD, PhD, Paul Nguyen, MD,…
Read more Treatment decisions in new era of individualized therapy for metastatic hormone-sensitive prostate cancer guided by Dana-Farber case studyNewswise — HOUSTON ― A new study led by researchers at The University of Texas MD Anderson Cancer Center, published today in Nature Medicine, provides a deeper understanding…
Read more Pan-cancer T cell atlas reveals new details of tumor microenvironmentNewswise — Researchers at Washington University School of Medicine in St. Louis have identified four important signs and symptoms that signal an elevated risk of early-onset colorectal cancer.…
Read more Red flags indicate risk for early-onset colorectal cancerNewswise — Each year, Connecticut Magazine recognizes some of the state’s best physicians, who provide exceptional care for patients, with its annual “Top Doctors” issue. This year’s list includes 82…
Read more Connecticut Magazine’s 2023 “Top Doctors” issue recognizes 82 Smilow Cancer Hospital and Yale Cancer Center physiciansNewswise — WASHINGTON — Discrimination experienced by Black people can affect their health and increase their frailty, which can be particularly impactful for cancer survivors, according to a…
Read more Study Finds Relationship Between Discrimination and Frailty in Black Cancer SurvivorsNewswise — A study in the Journal of The National Cancer Institute Cancer Spectrum looked at chatbots and artificial intelligence (AI), as they become popular resources for cancer…
Read more Can ChatGPT be Counted On?Newswise — ITHACA, N.Y. — An interdisciplinary collaboration 10 years in the making used a materials science approach to “fingerprint” the calcium mineral deposits known as microcalcifications that reveal…
Read more Microcalcification ‘fingerprints’ can yield info about cancerNewswise — Philadelphia, January 20, 2023—On the journey from gene to protein, a nascent RNA molecule can be cut and joined, or spliced, in different ways before being…
Read more CHOP Researchers Develop New, More Accurate Computational Tool for Long-Read RNA SequencingNewswise — LA JOLLA, CALIF. – Jan 05, 2023 – Cosimo Commisso, Ph.D., and Susanne Heynen-Genel, Ph.D., have received a grant from the National Cancer Institute (NCI) to advance…
Read more Sanford Burnham Prebys researchers team up to discover potential pancreatic cancer drugsNewswise — HOUSTON ― Researchers at The University of Texas MD Anderson Cancer Center have discovered a novel immunotherapy combination, targeting checkpoints in both T cells and myeloid…
Read more Study discovers triple immunotherapy combination as possible treatment for pancreatic cancerNewswise — Every year, up to 1% of patients with chronic lymphocytic leukemia (CLL), a slow-growing blood cancer, have their disease transform into a far more aggressive cancer,…
Read more Scientists Map Genetic Evolution of Chronic Lymphocytic Leukemia to Richter’s SyndromeNewswise — PHILADELPHIA (December 7, 2022) – While people with cancer have options to participate in cancer clinical trials (CCTs), it can be challenging when they encounter difficulties…
Read more Understanding How the Perception of Risks and Benefits Influence Cancer Clinical Trial Withdrawal OutcomesNewswise — HOUSTON – Patients with non-metastatic soft tissue sarcoma (STS) who need pre-operative radiation therapy can safely receive hypofractionated treatment over three weeks instead of five, with…
Read more Shorter Course of Radiation Therapy Yields Comparable Results for Patients with Non-Metastatic Soft Tissue Sarcoma
